| scholarly article | Q13442814 |
| P2093 | author name string | Dat Nguyen | |
| Andreas Moraitis | |||
| Kevin C J Yuen | |||
| P2860 | cites work | Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline | Q26772152 |
| 24-Hour monitoring of cortisol and corticotropin secretion in psychotic and nonpsychotic major depression | Q28142356 | ||
| Rapid reversal of psychotic depression using mifepristone | Q28191073 | ||
| DST studies in psychotic depression: a meta-analysis | Q28253516 | ||
| On the various forms of corticosteroid withdrawal syndrome | Q34285252 | ||
| Physiological basis for the etiology, diagnosis, and treatment of adrenal disorders: Cushing's syndrome, adrenal insufficiency, and congenital adrenal hyperplasia | Q34431162 | ||
| Clinical and biological effects of mifepristone treatment for psychotic depression | Q34450697 | ||
| Mifepristone versus placebo in the treatment of psychosis in patients with psychotic major depression | Q34554362 | ||
| Global clinical response in Cushing's syndrome patients treated with mifepristone | Q34629187 | ||
| Endocrine withdrawal syndromes | Q35200344 | ||
| Sustained weight loss in patients treated with mifepristone for Cushing's syndrome: a follow-up analysis of the SEISMIC study and long-term extension | Q35823679 | ||
| Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline | Q35916555 | ||
| Impact of mifepristone, a glucocorticoid/progesterone antagonist, on HDL cholesterol, HDL particle concentration, and HDL function. | Q35921379 | ||
| The steroid withdrawal syndrome: a review of the implications, etiology, and treatments | Q36729171 | ||
| Mifepristone Accelerates HPA Axis Recovery in Secondary Adrenal Insufficiency | Q37144269 | ||
| Differences in adverse effect reporting in placebo groups in SSRI and tricyclic antidepressant trials: a systematic review and meta-analysis | Q37610143 | ||
| Clinical Review#: The diagnosis and management of central hypoadrenalism | Q37780884 | ||
| A new therapeutic approach in the medical treatment of Cushing's syndrome: glucocorticoid receptor blockade with mifepristone. | Q38075650 | ||
| Mifepristone reduces weight gain and improves metabolic abnormalities associated with risperidone treatment in normal men. | Q39888640 | ||
| RU486 (mifepristone): mechanisms of action and clinical uses | Q41360492 | ||
| ASSOCIATION BETWEEN MIFEPRISTONE DOSE, EFFICACY, AND TOLERABILITY IN PATIENTS WITH CUSHING SYNDROME. | Q41631906 | ||
| Plasma concentrations and receptor binding of RU 486 and its metabolites in humans | Q42217667 | ||
| Mifepristone treatment of olanzapine-induced weight gain in healthy men. | Q43248853 | ||
| Efficiency and tolerance of mitotane in Cushing's disease in 76 patients from a single center | Q43843356 | ||
| A multisite trial of mifepristone for the treatment of psychotic depression: a site-by-treatment interaction | Q46076473 | ||
| An 8-week open-label trial of a 6-day course of mifepristone for the treatment of psychotic depression | Q46079014 | ||
| Steroid withdrawal syndrome after successful treatment of Cushing's syndrome: a reminder | Q46630243 | ||
| Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing's syndrome | Q48460262 | ||
| Efficacy and safety of mifepristone for the treatment of psychotic depression | Q48844419 | ||
| Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome | Q68260118 | ||
| Ketoconazole therapy: an efficacious alternative to achieve eucortisolism in patients with Cushing's syndrome | Q80096698 | ||
| Ketoconazole in Cushing's disease: is it worth a try? | Q87179331 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International | Q24082749 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P921 | main subject | adrenal insufficiency | Q2507454 |
| P304 | page(s) | 237-246 | |
| P577 | publication date | 2017-02-21 | |
| P1433 | published in | Journal of the Endocrine Society | Q50817780 |
| P1476 | title | Evaluation of Evidence of Adrenal Insufficiency in Trials of Normocortisolemic Patients Treated With Mifepristone. | |
| P478 | volume | 1 |
| Q92186506 | Mifepristone Treatment in Four Cases of Primary Bilateral Macronodular Adrenal Hyperplasia (BMAH) | cites work | P2860 |
Search more.